Melatonin: Dosing, Timing and the Science Beyond Sleep
Most melatonin sold in stores contains 10-20 times the dose your pineal gland actually produces. The research does not support "more is better" — it supports precision. Here is what the pharmacology, circadian biology, and antioxidant data actually show.
What Melatonin Actually Is: A Timing Signal, Not a Sedative
Melatonin is a hormone produced by the pineal gland, synthesized from serotonin (itself derived from tryptophan) in a light-sensitive pathway. Its release is suppressed by light and triggered by darkness, controlled by the suprachiasmatic nucleus (SCN) — the brain's master circadian clock, located in the hypothalamus.
This distinction matters clinically: melatonin is fundamentally a timing signal that tells the body "it is biological night," not a sedative-hypnotic that forces unconsciousness. This is why melatonin's effect on sleep onset latency, while real and reproducible, is modest compared to drugs like zolpidem or benzodiazepines — and why melatonin's more unique value lies in circadian realignment (jet lag, shift work, delayed sleep phase syndrome) rather than as a nightly sedative for people whose circadian clock is already well-aligned.
Endogenous Secretion Pattern
In a healthy adult with normal light exposure, melatonin begins rising roughly two hours before habitual bedtime, peaks in the middle of the night, and falls sharply with morning light exposure. Total nightly secretion is estimated in the range of a few tenths of a milligram — a genuinely small quantity compared to what is commercially sold.
Bioavailability note: Oral melatonin undergoes substantial first-pass hepatic metabolism via CYP1A2, with estimated bioavailability around 15%, though this varies significantly between individuals based on liver enzyme activity, age, and even smoking status (a CYP1A2 inducer). This variability is one reason individual response to identical doses differs so much from person to person.
The Dose Mismatch: Why Less Is Often More
Commercial melatonin products commonly contain 3mg, 5mg, or 10mg per dose — roughly 10 to 20 times the amount the body produces naturally in an entire night. This is a product-formulation artifact, not a dosing recommendation grounded in the strongest sleep-onset research.
The Zhdanova Low-Dose Finding
Zhdanova et al. (1995, published in Sleep) directly compared 0.3mg, 1.0mg, and 3.0mg doses for sleep onset latency and found that the 0.3mg dose — the closest to physiological — was as effective as the higher doses, while producing blood melatonin concentrations and elimination patterns most similar to natural nighttime secretion. This finding has been influential in shifting expert opinion toward low-dose protocols, though it has not fully permeated the consumer supplement market, where higher doses remain more commonly sold and marketed as stronger.
Why Higher Doses Aren't Simply "Stronger"
Melatonin receptors (MT1 and MT2) can be saturated at relatively low circulating concentrations. Once receptors are saturated, additional melatonin does not proportionally increase the signal — it primarily prolongs the duration that circulating melatonin remains elevated, which is part of why high doses are more strongly associated with residual next-morning grogginess. There is also preclinical evidence that sustained supraphysiological dosing may downregulate receptor sensitivity over time, an argument for reserving higher doses (5-10mg) for occasional, short-term use — such as a single night of significant jet lag — rather than nightly long-term use.
As an Amazon Associate, StackProtocol earns from qualifying purchases.
Timing Matters More Than Dose: Circadian Phase Shifting
Because melatonin functions as a timing signal to the SCN, its effect depends heavily on when during your circadian cycle it is taken — not just how much. This is best understood through the phase response curve (PRC): melatonin taken in the early evening (relative to your internal clock) produces a phase advance (shifts your clock earlier, helpful for early risers or eastward jet lag); taken in the early morning it can produce a phase delay (shifts your clock later) — effectively the opposite of the intended effect if timed incorrectly.
Practical Timing for Common Scenarios
- Routine sleep support: 30-60 minutes before your target bedtime, at a consistent time nightly, using a low dose (0.3-1mg).
- Eastward jet lag (losing time, e.g., flying US to Europe): Take a moderate dose near the destination's target bedtime for the first several nights, which produces a phase advance to match the new, earlier local night.
- Westward jet lag (gaining time): Melatonin is generally less necessary, since westward travel is an easier phase delay for most circadian systems to accommodate naturally; light exposure timing matters more here.
- Shift work: Timing should be anchored to the desired sleep window relative to the individual's new schedule, ideally combined with strategic light exposure and avoidance — melatonin alone rarely fully corrects shift-work circadian misalignment.
Light Exposure Is the Dominant Circadian Signal
Melatonin supplementation works best as a complement to light management, not a replacement for it. Morning bright light exposure and evening light avoidance (particularly blue-wavelength light, which most potently suppresses endogenous melatonin release) remain the strongest levers on circadian phase. Melatonin supplementation without corresponding light hygiene produces a substantially weaker realignment effect in the research literature.
Beyond Sleep: Antioxidant and Mitochondrial Research
Melatonin's biological role extends well beyond circadian signaling. It is synthesized locally in mitochondria at concentrations reported to be substantially higher than circulating blood levels, and it functions as a direct free radical scavenger and an upregulator of the body's own antioxidant enzyme systems, including superoxide dismutase and glutathione peroxidase.
What the Preclinical Data Shows
In animal and cell-culture models, melatonin has demonstrated protective effects against oxidative stress in neurons, reduced markers of mitochondrial dysfunction, and extended lifespan in several invertebrate and rodent studies. These findings have fueled substantial interest in melatonin as a candidate longevity compound, distinct from its sleep applications.
Evidence-based caveat: The antioxidant and longevity data in humans is considerably thinner than the sleep-onset data. Most of the striking lifespan-extension findings come from animal models, and translating antioxidant biomarker changes in humans into a demonstrated effect on healthspan or lifespan has not been established in controlled human trials. This is a genuinely promising research area, not a settled clinical benefit — treat longevity claims for melatonin with appropriate skepticism relative to its well-established sleep-timing evidence.
Immune Modulation
Melatonin also interacts with the immune system, generally in an immunomodulatory rather than purely immunostimulatory fashion. This is precisely why individuals with autoimmune conditions are advised to use caution and consult a physician before regular supplementation — the same property that makes melatonin interesting for inflammation research is the property that warrants care in autoimmune contexts.
As an Amazon Associate, StackProtocol earns from qualifying purchases.
Melatonin Forms: Immediate-Release vs. Extended-Release
| Form | Release Profile | Best For | Verdict |
|---|---|---|---|
| Immediate-release (tablet/capsule) | Rapid peak within 30-60 minutes, cleared within a few hours | Sleep onset difficulty, jet lag, situational use | Most Versatile |
| Extended/time-release | Gradual release mimicking natural overnight secretion curve | Middle-of-the-night waking, sleep maintenance | Sleep Maintenance |
| Sublingual/liquid | Bypasses some first-pass hepatic metabolism, faster onset | Those with inconsistent response to oral tablets | Situational Upside |
| Gummies (commonly 5-10mg) | Immediate-release, but frequently supraphysiological dosing per unit | Convenience, less precise dosing control | Check the Label |
Regardless of form, check labeled dose carefully — many gummies and chewables default to 5-10mg per serving, well above the physiological range most nightly-use research supports.
before bed
or before bed
before bed
This combination addresses three distinct sleep bottlenecks: circadian timing signal (melatonin), physical relaxation (magnesium), and cognitive quieting (L-theanine). Each targets a different mechanism, so effects are additive rather than redundant.
Practical Protocol: Choosing Dose and Timing by Goal
- Nightly circadian support: Start at 0.3mg, 30-60 minutes before target bedtime, at a consistent clock time every night. Only increase toward 1-3mg if no effect is noticeable after 1-2 weeks of consistent low-dose use.
- Sleep maintenance (waking at 3am): Consider an extended-release formulation instead of increasing immediate-release dose — the goal is a sustained low level through the night, not a higher peak early on.
- Jet lag: Identify your destination's target bedtime before departure. Begin taking a moderate dose (1-5mg) near that target bedtime starting on travel day, continuing for 2-4 nights after arrival, paired with morning light exposure at the destination.
- Reserve high doses for situational use: Doses above 3mg are best treated as an occasional tool (overnight flights, acute circadian disruption) rather than a nightly baseline, given the receptor-saturation and downregulation considerations discussed above.
- Review with a physician if applicable: Anyone on anticoagulants, immunosuppressants, or diabetes medications, or with an autoimmune condition, should discuss melatonin use with their prescribing physician before starting regular supplementation.